Verenium and BP Extend Galaxy Joint Development Program
News Mar 09, 2010
Verenium Corporation has announced that it has extended the joint development program established in August 2008 with partner BP for an additional month until April 1, 2010. BP and Verenium will continue their ongoing joint development work to accelerate the development and commercialization of cellulosic ethanol, while the two parties continue negotiations for a longer-term collaboration. Verenium will receive an additional $2.5 million from BP to co-fund the cellulosic ethanol program for the month of March.
"Both Verenium and BP remain committed to advancing our cellulosic ethanol technology and agreeing on an appropriate structure for doing so," said Carlos A. Riva, President and Chief Executive Officer at Verenium.
The material terms of this extension agreement are described in more detail in the Company's Current Report on Form 8-K filed on March 1, 2010 with the Securities and Exchange Commission.
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Revealing How Dietary Fat Affects Stem Cell DifferentiationNews
A recent study suggests a general mechanism by which dietary fats affect cellular physiology through remodeling of membrane lipidomes, biophysical properties and signaling.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE